DOCSLIB.ORG

Acute Stroke Decision-Making in Historical and Philosophical Context, 1960-2014

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Acute Stroke Decision-Making in Historical and Philosophical Context, 1960-2014 University of Calgary PRISM: University of Calgary's Digital Repository Graduate Studies The Vault: Electronic Theses and Dissertations 2014-07-18 Acute Stroke Decision-Making in Historical and Philosophical Context, 1960-2014 Shamy, Michel Christopher Frank Shamy, M. C. (2014). Acute Stroke Decision-Making in Historical and Philosophical Context, 1960-2014 (Unpublished master's thesis). University of Calgary, Calgary, AB. doi:10.11575/PRISM/24697 http://hdl.handle.net/11023/1648 master thesis University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission. Downloaded from PRISM: https://prism.ucalgary.ca UNIVERSITY OF CALGARY Acute Stroke Decision-Making in Historical and Philosophical Context, 1960-2014 by Michel Christopher Frank Shamy A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF ARTS DEPARTMENT OF HISTORY PROGRAM IN THE HISTORY AND PHILOSOPHY OF SCIENCE CALGARY, ALBERTA JULY, 2014 © Michel Christopher Frank Shamy 2014 ii Abstract This thesis applies approaches from the history and philosophy of science to explore the decision- making of contemporary physicians in a common clinical scenario: the treatment of patients with acute stroke. Acute stroke decision-making during the period 1960 to 2014 therefore serves as a case study to address broader questions about how doctors make decisions. I argue that acute stroke decision-making is dependent upon a historically-determined concept of the acute stroke, in that the contemporary meaning of the disease “acute stroke” was established in response to the efficacy of the drug tissue plasminogen activator (tPA) as its treatment. Moreover, I propose that treatment decisions about the use of tPA for acute stroke involve simultaneous and inter-related processes of epistemic and ethical evaluation. Acute stroke decision- making can therefore be conceived as a medical, epistemic and ethical process, occurring within a historical context. This interpretation of acute stroke decision-making argues for the necessary role of the humanities — and especially of the history and philosophy of science — in the study of modern medical practice. iii Acknowledgements The path that has led to this thesis began in New Haven, and wound its way through Kingston, Toronto, San Francisco, Calgary and Ottawa. First, I would like to thank my undergraduate professors — among them Ted Bromund, Robin Winks, Joanne Freeman, and George Fayen — for teaching me to think and to write. I was inspired to apply a historical and philosophical approach to studying medicine through the writings and teachings of Drs. Jacalyn Duffin of Queen’s University and Ross Upshur of the University of Toronto. I must thank the many patients who, over the course of my clinical training, allowed me to participate in their care, and from whom I learned so much about stroke, about doctors, and about myself. I extend my thanks to Department of History at the University of Calgary for having accepted me into the Graduate Program in the History and Philosophy of Science (HPS). I would not have gotten to this point without the support and supervision of Professor Frank Stahnisch, whose mentorship has made me a better student, writer, scholar and doctor. I also would like to thank my committee — Professors Henderikus Stam, Megan Delehanty, Paul Chastko and Eric Smith — for their willingness to share in this process, and for their engagement to make this thesis as good as it can be. I have to thank Alberta Innovates – Health Solutions, without whose financial support it would not have been possible for me to complete this master’s degree. Funding from the Ottawa Hospital Research Institute, the Canadian Stroke Consortium and the American Academy of Neurology has also been much appreciated. I would also like to thank the Calgary Stroke Program — Drs. Andrew Demchuk, Michael Hill and Eric Smith especially — for their belief in my ability to make a meaningful contribution to clinical care through an HPS approach. I have to thank Drs. Phil Wells, David Grimes, Grant Stotts and Dar Dowlatshahi in the Department of Medicine at the University of Ottawa for their financial support, flexibility, and encouragement over the course of the last year. iv Finally, I have to thank my friends and family, for believing in me and caring for me all along this road. Mark Fedyk, I must thank you for being such a wonderful friend, mentor, and sounding board. Thank you, Mom and Dad, for all you have done over the last 33 years. Most importantly, your brilliance, dedication and kindness were, are, and always will be, an inspiration. And to Claire: 1000 thank yous to go along with the 1000 times I have fallen in love with you. This would not have been possible without you. v Dedication For my parents, with love vi Table of Contents Abstract ii Acknowledgements iii Dedication v Table of Contents vi List of Figures & Illustrations viii Glossary ix Epigraph xv Introduction 1 How Do Doctors Make Decisions? 1 Perspectives on Medical Decision-Making 5 Rationalistic Approaches to Decision-Making 12 Heuristic Approaches to Decision-Making 16 Social Psychological Approaches to Decision-Making 21 Approaches to Decision-Making from the History & Philosophy of Science 26 The Case of Acute Stroke Decision-Making 30 Outline 37 Chapter 1: The Meaning of “Acute Stroke” 40 Introduction 40 History, Epistemology & Ontology 41 A Brief Historiography of Stroke 51 Treatability & Time 56 Acuity & the Acute Stroke 60 Acute Stroke & the NINDS Trial 63 Preconditions of the Acute Stroke 72 Vascular Anatomy 74 Localizability of Pathology 77 Ischemia and Hemorrhage 78 CT Scans 81 Thrombolysis 85 Penumbra 88 Conclusions 92 Chapter 2: Epistemic Evaluation in Acute Stroke Decision-Making 96 Introduction 96 Propositions, Beliefs & Knowledge 98 Epistemic Evaluation & Evidence-Based Medicine 104 Acute Stroke & its Clinical Propositions 112 Epistemology, History & Treatability 118 Conclusions 129 vii Chapter 3: Ethical Evaluation in Acute Stroke Decision-Making 133 Introduction 133 Principlist Ethics & Everyday Medical Decisions 134 Causes, Consequences & Values in Acute Stroke Decision-Making 142 Evaluating Post-Stroke Outcomes 152 Evaluating Pre-Stroke States 158 Conclusions 164 Conclusions 169 Acute Stroke Decision-Making 169 Implications for Physician Decision-Making 175 Bibliography 181 Primary Sources 181 Secondary Sources 193 viii List of Figures & Illustrations Figure 1. CT Scan of the Brain depicting ischemic stroke 34 Figure 2. Digital Subtraction Angiogram of the Brain 35 Figure 3. “Acute Stroke” in MEDLINE 66 Figure 4. “Acute Stroke” in MEDLINE 67 Figure 5. CT Scan of the Brain depicting intracerebral hemorrhage 84 ix Glossary American Heart Association: American charitable organization that funds research into diseases of the heart and vascular system and that establishes national guidelines for the care of patients with these diseases; founded in 1924. Angiogram: An image that depicts blood vessels and the flow of blood through them. In relation to the brain, several techniques may be used. In digital subtraction angiography, catheters are advanced into the chest, neck or head, and radio-opaque dye is injected to depict the flow of blood through vessels in real- time. In CT angiography, radio-opaque dye is injected into the vein and the patient undergoes a CT scan, with an image produced depicting the presence of radio-opaque dye in the arteries or veins at a particular point in time. Aphasia: The inability to produce or comprehend language. A common symptom of stroke, most commonly associated with occlusions of the left middle cerebral artery. Apoplexy: A historical term derived from the Greek for being “struck down.” Over time, it has been used to refer to: any sudden loss of consciousness; the sudden onset of neurological symptoms; intracerebral hemorrhage. Artery: A vessel that carries blood away from the heart and towards the body’s tissues. x Cerebral Venous Sinus Thrombosis: A condition in which the veins of the brain or head may become blocked, potentially producing a back up of blood being drained from the head. May lead to hemorrhage into the brain. Central Nervous System (CNS): The brain and spinal cord. In contrast to the peripheral nervous system (PNS), which includes the nerves that run from the spinal cord to the muscles and skin. Computerized Tomography (CT): A technique to visualize the brain or other internal organs using x- ray based technology that resolves organs and tissues of shades of black or white. Epidural Hematoma: Bleeding into the space between the skull and the lining of the brain, most commonly produced by injury to the middle meningeal artery that runs through the skull just above the ear. May present as the sudden onset of neurological symptoms or loss of consciousness. Often fatal if not treated immediately. Heart and Stroke Foundation: Canadian charitable organization that funds research into heart and brain disorders, and advocates for patients at various levels of government. Hemiplegia: The inability to move one side of the body, such as the face, arm and leg. A common symptom of ischemic stroke or intracerebral hemorrhage. Hemorrhage: The release of blood into an organ or tissue, usually resulting from the rupture of an artery. xi Hypoxic-Ischemic Encephalopathy: A condition in which the whole brain is temporarily deprived of blood flow and oxygen delivery. Occurs in the setting of low blood flow due to blood loss, impaired heart function, or low blood pressure. Most often presents as loss of consciousness. Infarction: A general term that refers to the death of tissue from ischemia (impaired blood flow). Intracerebral: Within the brain. Intracerebral Hemorrhage: Bleeding into the substance of the brain, most commonly due to a small artery.
Load more

Recommended publications
  • ANNUAL REPORT 1981-1982 Montreal Neurological Hospital Montreal Neurological Institute
    VAll ANNUAL REPORT 1981-1982 Montreal Neurological Hospital Montreal Neurological Institute 47th Annual Report Montreal Neurological Hospital Montreal Neurological Institute 1981-1982 (Version francaise disponible sur demande.) Table of Contents Montreal Neurological Hospital Neurogenetics 86 Board of the Corporation 7 Neuromuscular Research 89 Board of Directors 8 Neuro-ophthalmology 91 Council of Physicians Executive 10 Neuropharmacology 92 Clinical and Laboratory Staff 12 Research Computing 94 Consulting and Visiting Staff 17 William Cone Laboratory 95 Professional Advisors 19 Resident and Rotator Staff 20 Education Clinical and Laboratory Fellows 21 Clinical Training Opportunities 101 Nursing Administration and Courses of Instruction 105 Education 23 Post-Basic Nursing Program 107 Graduates of Post-Basic Nursing Program 25 Publications 111 Administrative Staff 26 Supervisory Officers 26 Finances Executive of the Friends of the Neuro Montreal Neurological Hospital 127 27 Montreal Neurological Institute 131 Clergy 27 Endowments 132 Grants for Special Projects 133 Montreal Neurological Institute MNI Grants 135 Neurosciences Advisory Council 31 Donations 136 Advisory Board 32 Suggested Forms for Bequests 139 Scientific Staff 34 Academic Appointments, McGill 36 Statistics Executive Committee 40 Classification of Operations 143 Research Fellows 41 Diagnoses 146 Causes of Death 147 Director's Report 45 Hospital Reports Neurology 53 Neurosurgery 55 Council of Physicians 57 Nursing 59 Administration 62 Finance 64 Social Work 65 Institute Reports El El Experimental Neurophysiology 74 Fellows' Library 77 Muscle Biochemistry 78 Neuroanatomy 80 Neurochemistry 82 Montreal Neurological Hospital In April 1983 Dr. William Feindel, director of the Montreal Neurological Institute and director-general of the Montreal Neurological Hospital was named an officer of the Order of Canada.
    [Show full text]
  • News Release
    NEWS RELEASE: June 14, 2005 Health care leaders create Canada’s first national health advisory body The Canadian Academy of Health Sciences will give Government and the public comprehensive expertise and advice on health issues EDMONTON - When the President of the United States wants advice on a public health issue, he calls the United States’ National Academies. When the Prime Minister of Great Britain wants to seek similar counsel, he usually turns to the Royal Society of Britain. But when the Prime Minister of Canada wants similar advice, who does he call? Well, that’s not always entirely clear, given the more narrowly defined mandates of many Canadian organizations. Now, however, owing to a recent initiative by a group of leading health care leaders and researchers, the Prime Minister will be able to call the Canadian Academy of Health Sciences (CAHS), recently created to: • Develop informed, strategic assessments on urgent health issues; • Inform public policy on these issues; • Enhance Canada’s readiness to deal with global health issues; and, • Provide a recognized and authoritative Canadian health science voice internationally. According to one of the Academy’s key organizers, the establishment of the Academy is long over due—and all the more pressing given the potential global health threats to Canadians, most recently exemplified by the SARS threat. “Ask Canadians what they care about most, and they answer unequivocally: ‘health,’” explains University of Alberta Professor of Medicine Paul Armstrong, CAHS’s first president. “It makes sense, therefore, that Canada should have an organization that government—and Canadians—can turn to for sound, impartial advice and research on pressing health issues.” The organization will also have an international role to play, representing Canada’s interests abroad and working closely with other nations’ parallel agencies.
    [Show full text]
  • Printable List of Laureates
    Laureates of the Canadian Medical Hall of Fame A E Maude Abbott MD* (1994) Connie J. Eaves PhD (2019) Albert Aguayo MD(2011) John Evans MD* (2000) Oswald Avery MD (2004) F B Ray Farquharson MD* (1998) Elizabeth Bagshaw MD* (2007) Hon. Sylvia Fedoruk MA* (2009) Sir Frederick Banting MD* (1994) William Feindel MD PhD* (2003) Henry Barnett MD* (1995) B. Brett Finlay PhD (2018) Murray Barr MD* (1998) C. Miller Fisher MD* (1998) Charles Beer PhD* (1997) James FitzGerald MD PhD* (2004) Bernard Belleau PhD* (2000) Claude Fortier MD* (1998) Philip B. Berger MD (2018) Terry Fox* (2012) Michel G. Bergeron MD (2017) Armand Frappier MD* (2012) Alan Bernstein PhD (2015) Clarke Fraser MD PhD* (2012) Charles H. Best MD PhD* (1994) Henry Friesen MD (2001) Norman Bethune MD* (1998) John Bienenstock MD (2011) G Wilfred G. Bigelow MD* (1997) William Gallie MD* (2001) Michael Bliss PhD* (2016) Jacques Genest MD* (1994) Roberta Bondar MD PhD (1998) Gustave Gingras MD* (1998) John Bradley MD* (2001) Phil Gold MD PhD (2010) Henri Breault MD* (1997) Richard G. Goldbloom MD (2017) G. Malcolm Brown PhD* (2000) Jean Gray MD (2020) John Symonds Lyon Browne MD PhD* (1994) Wilfred Grenfell MD* (1997) Alan Burton PhD* (2010) Gordon Guyatt MD (2016) C H G. Brock Chisholm MD (2019) Vladimir Hachinski MD (2018) Harvey Max Chochnov, MD PhD (2020) Antoine Hakim MD PhD (2013) Bruce Chown MD* (1995) Justice Emmett Hall* (2017) Michel Chrétien MD (2017) Judith G. Hall MD (2015) William A. Cochrane MD* (2010) Michael R. Hayden MD PhD (2017) May Cohen MD (2016) Donald O.
    [Show full text]
  • Prospectus for a Major Assessment: the Return on Investments in Health Research
    Prospectus for a Major Assessment: The Return on Investments in Health Research: Defining the Best Metrics Prepared by the Canadian Academy of Health Sciences May 2007 WO The Return on Investments in Canadian Health Research – The Situation Investments in health research have increased significantly across Canada over the past decade. Naturally, and justifiably, with these greater investments come increased expectations. In addition, the widening diversity of stakeholders engaged in and/or supporting health research has led to a broader range of anticipated outcomes. These expectations include: 1] better health; 2] greater life expectancy; 3] translation of research findings into improvements in quality of life; 4] informed public policy on health related issues across the full spectrum of government and private sector activity; 5] new commercial opportunities within and beyond Canadian borders; 6] increased attraction of the next generation to pursue careers in health research and the health sector; 7] a better ‘state of readiness” for the unexpected threats to health that inevitably develop in the contemporary world. In parallel with these expectations, a confluence of factors has placed intense focus on understanding what return our society receives for the investments made in health research. Some of these include: • lack of public understanding of the value of research and its applicability to current issues in health care at a time of unsurpassed concern about accessible, affordable, high quality health care in a publicly funded
    [Show full text]
  • ANNUAL REPORT 1978/1979 Montreal Neurological Hospital Montreal Neurological Institute
    ANNUAL REPORT 1978/1979 Montreal Neurological Hospital Montreal Neurological Institute 44th Annual Report Montreal Neurological Hospital Montreal Neurological Institute 1978-1979 "table of Contents Montreal Neurological Neuroanatomy 68 Hospital Neuroanesthesiology 69 Board of the Corporation 7 Neurochemistry 70 Board of Directors 8 Neurogenetics 72 Clinical and Laboratory Staff 10 Neuro-isotope Laboratories 74 Consulting and Adjunct Staff 14 William Cone Laboratory for Resident and Rotator Staff 16 Neurosurgical Research 74 CUnical and Laboratory Fellows 17 Brain Scan Department 75 Nursing Staff 18 Neuromuscular Research Nursing Graduates 19 Laboratory 76 Administrative Staff 20 Neuro-ophthalmology 77 Supervisory Officers 20 Neuropathology 78 Auxiliary of the Royal Victoria Neuropharmacology 79 Hospital 21 Neurophotography 80 Clergy 21 Neuropsychiatry 81 Neuropsychology 82 Montreal Neurological Institute Neuroradiology 84 Neurosciences Advisory Council 25 Advisory Board 26 Education Executive Committee 28 Clinical Training Opportunities 87 MNH/MNI Academic Appoint­ Neurology 87 ments in the Department Neurosurgery 89 of Neurology and Neuro­ Courses of Instruction 91 surgery, McGill University 29 Post-Basic Course in Research Fellows 31 Neurological and Neuro­ surgical Nursing 92 Reports Principal's Remarks 35 Societies Director's Report 37 Fellows' Society 95 Montreal Neurological Society 96 Hospital Reports Neurology 47 Publications 99 Neurosurgery 49 Nursing 51 Finances Administration 53 Hospital Financial Statements in Finance 54 Institute
    [Show full text]
  • Moving Forward Canadian Institutes of Health Research Annual Report 2010–11 1 Canadian Institutes of Health Research Annual Report 2010–11 Moving Forward
    MOVING FORWARD CANADIAN INSTITUTES OF HEALTH RESEARCH ANNUAL REPORT 2010–11 1 CANADIAN INSTITUTES OF HEALTH RESEARCH ANNUAL REPORT 2010–11 MOVING FORWARD CIHR is the Government of Canada’s agency for health research. Its mandate is to “excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened Canadian health-care system.” For the past 10 years, the Canadian Institutes of Health Research (CIHR) has supported better health and health care for Canadians. As the Government of Canada’s health research investment agency, CIHR enables the creation of evidence-based knowledge and its transformation into improved treatments, prevention and diagnoses, new products and services, and a stronger, patient-oriented health-care system. Composed of 13 internationally recognized Institutes, CIHR supports more than 14,100 health researchers and trainees across Canada. Canadian Institutes of Health Research 160 Elgin Street, 9th Floor Address Locator 4809A Ottawa, Ontario K1A 0W9 Canada www.cihr-irsc.gc.ca Also available on the Web in PDF and HTML formats © Her Majesty the Queen in Right of Canada (2011) Cat. No. MR1-2011E-PDF ISSN 1701-9222 All people profiled in this annual report have agreed to their appearance in it and approved their individual stories. Funding by Program Type 1999–2000/2009–10 Including CRC, CECR, and NCE (in millions of dollars) Expenditures $1,000 $900 $800 $700 $600 $500 $400 $300 1999-2000 2009-2010 $200 British Columbia $ 25 $ 125 $100 Prairies Province $ 48 $ 98 $0 Ontario $ 114 $ 350 99-00 00-01 01-02 02-03 03-04 04-05 05-06 06-07 07-08 08-09 09-10 10-11 Quebec $ 88 $ 241 Fiscal Year Atlantic Provinces $ 9 $ 29 Councils (CRC, NCE, Strategic Operating CECR, CERC) Other * Operating budget gures are based on estimates.
    [Show full text]
  • CAHS Oral Formated
    Prospectus for a Major Assessment on Improving Access to Oral Health Care for Canadians Prepared by the Canadian Academy of Health Sciences March 2008 About the Canadian Academy of Health Sciences The Canadian Academy of Health Sciences is a non-profit organization composed of selected members from diverse disciplines both within and external to the health sector. It is both an honorific membership organization and a policy research organization. The Academy’s Fellows, elected on the basis of their professional achievement and commitment to service, are volunteers who bring their time and expertise to provide assessment and advice on difficult challenges of public policy of concern to all Canadians in the area of health and health care. Election to active Fellowship in the Academy is both an honour and a commitment to serve in Academy affairs. The Academy was created in 2004 and modelled on the Institute of Medicine of the United States that, since 1970, has worked outside the framework of government to ensure scientifically informed analysis and independent guidance on a variety of important public policy issues. The IOM's mission is to serve as adviser to the nation to improve health. The Institute provides unbiased, evidence-based, and authoritative information and advice concerning health and science policy to policy-makers, professionals, leaders in every sector of society, and the public at large. Below are examples of key IOM reports that have had an international impact on health policy: • To Err is Human: Building a Safer Health
    [Show full text]
  • Dossier Spécial Guide Pratique Étudiants
    Revue publiée par le FONDS DE LA RECHERCHE EN SANTÉ DU QUÉBEC NUMÉRO 39 • DÉCEMBRE 2007 DOSSIER SPÉCIAL Éditorial GUIDE PRATIQUE ÉTUDIANTS Former la rèleve : une DES BOURSES DE FORMATION AUX priorité PERSPECTIVES DE CARRIÈRE Sainte-Justine 1907-2007 D'hier à aujourd'hui – contrat no 40065390 – contrat Envoi de publication Envoi CONSEIL D’ADMINISTRATION DU FRSQ PRÉSIDENT-DIRECTEUR GÉNÉRAL M. ALAIN BEAUDET, M.D., PH. D. AUTRES MEMBRES MME MICHÈLE STANTON-JEAN, M.A., M.ÉD. (VICE-PRÉSIDENTE) M. RAYMUND J. WELLINGER, PH. D. (SECRÉTAIRE) M. JEAN-DENIS DUBOIS, M. SC. MME JOHANE GUAY, PH. D. 28 M. ANTOINE HAKIM, M.D., PH. D. M. JACQUES HENDLISZ MME TRANG HOANG, PH. D. MME LOUISE PILOTE, M.D., PH. D. MME MARIE-FRANCE RAYNAULT, M.D., M. SC. sommaire MME LISE R. TALBOT, PH. D. M. MICHEL L. TREMBLAY, PH. D. 3 éditorial M. PHILIPPE WALKER, PH. D. MME GENEVIÈVE TANGUAY, PH. D. (OBSERVATRICE) M. CLAUDE DUSSAULT (OBSERVATEUR) MME ISABELLE THIFFAULT, M. SC. (ÉTUDIANTE) 5 nouvelles du FRSQ COORDINATION DE LA REVUE 8 nouvelles de la communauté MICHELLE DUBUC, M. Sc. scientifique RÉDACTION MICHELLE DUBUC, LUC DUPONT, DOMINIQUE FORGET, DANIELLE OUELLET, NUMÉRO 39 LUC QUINTAL couverture : © Photodisc, 20 centres de recherche Archives historiques PRODUCTION du CHU Sainte-Justine Sainte-Justine 1907-2007. D'hier à aujourd'hui GRAPHISME LE GROUPE FLEXIDÉE LTÉE IMPRESSION IMPRIMERIE QUAD INC. FAIRE PARVENIR TOUTE 28 DOSSIER SPÉCIAL CORRESPONDANCE À L’ADRESSE SUIVANTE : SERVICE DES COMMUNICATIONS RECHERCHE EN SANTÉ GUIDE PRATIQUE ÉTUDIANTS 500, RUE SHERBROOKE OUEST, BUREAU 800 MONTRÉAL (QUÉBEC) H3A 3C6 TÉLÉPHONE : (514) 873-2114 DES BOURSES DE FORMATION TÉLÉCOPIEUR : (514) 873-8768 COURRIEL : [email protected] AUX PERSPECTIVES DE CARRIÈRE SITE WEB : www.frsq.gouv.qc.ca d Organisme mandataire du ministère du Ce dossier s’adresse d’abord et avant tout aux étudiants qui désirent acquérir Développement économique, de l’Innovation et de l’Exportation (MDEIE), le Fonds de la recherche une formation en recherche.
    [Show full text]
  • Investing in Each Other to Advance, Achieve and Excel Department of Medicine 2012–2013 Annual Report OUR VISION OUR VALUES
    CHARTING OUR COURSE: Investing in Each Other to Advance, Achieve and Excel Department of Medicine 2012–2013 Annual Report OUR VISION OUR VALUES To be recognized as the RESPECT #1 choice Department of Medicine We will treat patients, trainees, in Canada for patients, students, staff and colleagues with dignity and residents, fellows and staff. equity, recognizing individual, gender and cultural differences and diversity. QUALITY OUR MISSION We will always strive for excellence in patient care, research and education. We will perform the highest quality clinical research and medical COLLABORATION education in an environment that We will work together for the good focuses on quality and safety of care of all members of the Department, for all patients. The Ottawa Hospital and the University of Ottawa, to improve health, education and research in the Champlain LHIN. ACCOUNTABILITY We will value the highest standard for professionalism, fairness and transparency in an environment of, advocacy for, and accountability to, the communities we serve, as well as all members of the Department of Medicine. The Department of Medicine As a major department within the is an innovative academic health University of Ottawa, Faculty of care leader focused on advancing, Medicine, and The Ottawa Hospital, developing and delivering cutting- and valued partner of The Ottawa edge medical research, outstanding Hospital Research Institute, Ottawa’s patient care and high-quality Department of Medicine actively education that prepares future brings together close to twenty sub generations of health specialty medical divisions, physicians, care professionals. researchers, educators, administrators and future health care professionals Through strong and visionary in an open, inclusive, supportive and leadership and with its exceptional inspiring culture.
    [Show full text]
  • ANNUAL REPORT 1983/1984 Montreal Neurological Hospital Montreal Neurological Institute
    / ANNUAL REPORT 1983/1984 Montreal Neurological Hospital Montreal Neurological Institute 49th Annual Report Montreal Neurological Hospital Montreal Neurological Institute 1983-1984 (Version francaise disponible sur demande.) Table of Contents Montreal Neurological Hospital 5 Institute Research Reports 67 Board of the Corporation 7 Comments of the Director 69 Board of Directors 8 Developmental Neurobiology 71 Council of Physicians Executive 10 Muscle Biochemistry 72 Clinical and Laboratory Staff 12 Neuroanatomy 74 Consulting and Visiting Staff 16 Neuroanesthesiology 77 Professional Advisors 18 Neurochemistry 78 Resident and Rotator Staff 19 Neurogenetics 82 Clinical and Laboratory Fellows 20 Neurolinguistics 85 Nursing Department 22 Neuromuscular Research 87 Nursing Graduates 24 Neuro-otology 89 Administrative Staff 25 Neuropathology 90 Supervisory Officers 25 Neuropharmacology 92 Executive, Friends of the Neuro 26 Neurophysiology 94 Clergy 26 Neuropsychology 102 Neuroradiology 103 Montreal Neurological Institute 27 Neurosurgery 105 Neurosciences Advisory Council 29 Neurotoxicology 108 Advisory Board 30 Positron Emission Tomography Scientific Staff 32 Research 110 Academic Appointments, McGill 34 Executive Committee 36 Education 115 Research Fellows 37 Clinical Training Opportunities 117 Courses of Instruction 122 Director General's Report 39 Post Basic Program in Neurological and Neurosurgical Nursing 123 Hospital Reports 53 Neurology 55 Publications 125 Neurosurgery 57 Council of Physicians 58 Finances 135 Nursing 60 Montreal Neurological
    [Show full text]
  • Medextra Spring/Summer 2018
    our successes as we move as we together together forward Sharing MEDEXTRA Spring / Summer 2018 Table of Contents 1 Message from the Dean 2 Message from Advancement 3 Faculty of Medicine Homecoming Weekend 4 Philanthropy at Work: Profile of an All-Star Student 5 Alumni Spotlight: Reconstructing Bodies, Rebuilding Lives 7 Your Gifts Make a Difference: One Family’s Story 8 Spotlight on Our Undergraduate Programs Undergraduate Medical Education Translational and Molecular Medicine 12 Spotlight on Our Research The University of Ottawa Brain and Mind Research Institute Centre for Infection, Immunity and Inflammation Research Successes Faculty of Medicine Major Research Events 21 Faculty Affairs 21 Francophone Affairs 22 Internationalization and Global Health Dear Faculty of Medicine alumni, donors and friends, In our ongoing efforts to share the groundbreaking work in research and education at the Faculty of Medicine, we present to you the inaugural issue of MedExtra. Included are recent success stories from our various academic programs, as well as profiles that illustrate the great strides we are making in basic and clinical research. The past 12 months have been a period of impressive recognition for some of our faculty, including Dr. Antoine Hakim, awarded the 2017 Canada Gairdner Wightman Award for his pioneering work in stroke research and recovery, and Dr. Mona Nemer, named Chief Science Advisor to the Prime Minister of Canada. Taking time to look back on 2017 and celebrate the year’s accomplishments makes it all the more exciting to look ahead to the coming year and beyond. Every day brings new discoveries and Bernard better treatment for patients.
    [Show full text]
  • Lauréats Du Temple De La Renommée Médicale Canadienne
    Lauréats du Temple de la renommée médicale canadienne A Maude Abbott MD* (1994) E Albert Aguayo MD (2011) Connie J. Eaves PhD (2019) Oswald Avery MD* (2004) John Evans MD* (2000) B F Elizabeth Bagshaw MD* (2007) Ray Farquharson MD* (1998) Sir Frederick Banting MD* (1994) L’honorable Sylvia Fedoruk* (2009) Henry Barnett MD* (1995) William Feindel MD PhD* (2003) Murray Barr MD* (1998) B. Brett Finlay PhD (2018) Charles Beer PhD* (1997) C. Miller Fisher MD* (1998) Bernard Belleau PhD* (2000) James FitzGerald MD PhD* (2004) Philip B. Berger MD (2018) Claude Fortier MD* (1998) Michel G. Bergeron MD (2017) Terry Fox* (2012) Alan Bernstein PhD (2015) Armand Frappier MD* (2012) Charles H. Best MD PhD* (1994) F. Clarke Fraser MD PhD* (2012) Norman Bethune MD* (1998) Henry Friesen MD (2001) John Bienenstock MD (2011) Wilfred G. Bigelow MD* (1997) G Michael Bliss PhD* (2016) William Gallie MD* (2001) Roberta Bondar MD PhD (1998) Jacques Genest MD* (1994) John Bradley MD* (2001) Gustave Gingras MD* (1998) Henri Breault MD* (1997) Phil Gold MD PhD (2010) G. Malcolm Brown PhD* (2000) Richard G. Goldbloom MD (2017) John Symonds Lyon Browne MD PhD* (1994) Jean Gray MD (2020) Alan Burton PhD* (2010) Wilfred Grenfell MD* (1997) Gordon Guyatt MD (2016) C G. Brock Chisholm MD (2019) H Harvey Max Chochinov MD PhD (2020) Vladimir Hachinski MD (2018) Bruce Chown MD* (1995) Antoine Hakim MD PhD (2013) Michel Chrétien MD (2017) Juge Emmett Hall* (2017) William A. Cochrane MD* (2010) Judith G. Hall MD (2015) May Cohen MD (2016) Michael R. Hayden MD PhD (2017) James Collip MD PhD* (1994) Donald O.
    [Show full text]